The Network Advantage: three Models, one Goal: scaling site success
Join us for an in-depth conversation on effective strategies for growing your site within today’s evolving clinical research landscape. Hear from subject matter experts representing 3 leading site networks as they share proven approaches to expanding site business by leveraging multi-site network models.
The Network Advantage: defining and recognizing quality in clinical research
Join us as we present the findings of AMRC’s 2025 industry consultation on quality in clinical research and outline the steps the association will take to define and recognise quality in practice.
The Network Advantage: We can define speed but why can’t we define quality in clinical research?
Join the Association of Multisite Research Corporations (AMRC) for an exclusive webinar unpacking the key findings from our latest whitepaper and industry consultation on quality in multisite clinical research.
The Network Advantage: A Regulatory Perspective on Clinical Research Innovation with the FDA’s David Burrow
While he’s a firm believer in the entire clinical trial process, for Carlos Orantes, Chief Executive Officer at Alcanza Clinical Research, there’s an unmistakable ‘magic’ to be found in late-stage trials. “You’re that much closer to bringing lifesaving and enhancing drugs and devices to patients by collaborating with other dedicated professionals,” he says.
The Network Advantage: A Regulatory Perspective on Clinical Research Innovation
In this informative session, clinical trial professionals will have an opportunity to hear directly from the FDA’s David Burrow on ways industry can advance clinical trial innovation.
“We’re Not Giving Up Control, We’re Just Sharing it” Highlights from AMRC’s Latest Webinar on Sponsor Pain Points
The Association of Multisite Research Corporations (AMRC), the leading trade association representing multisite clinical research corporations (MCRCs), announces Jennifer Byrne, CEO of Javara, as its newest member of the Board of Directors.
Identifying the pain points that stop Sponsors and CROs from working with sites
In this candid conversation, representatives from the clinical trial ecosystem will discuss how they can work with sites more effectively. We will use the session to identify key issues and blockers that prevent Sponsors and CROs from engaging with multisite clinical research corporations (MCRCs).
Capitol Hill Forecast – What Should MCRCs Prepare For?
Join Patrick Cooney, a seasoned expert with bipartisan insight into healthcare policy, as we explore the federal government’s priorities and funding outlook for clinical research.
Operational inefficiency in clinical research: what is it costing Sponsors and CROs?
The Association of Multisite Research Corporations (AMRC) welcomes a panel of experts to discuss the financial and operational impact of inefficiency in clinical trials. We’ll be joined by representatives from regulatory, academic, pharma, and trial sites, who will share their perspectives on the challenges facing the industry and possible solutions to streamline trials, improve data quality, and bring therapies to patients faster.
